Health r&d services; health care services; basic research (AN11): United States public contracts since 2024

Updated 17 October 2026 · all lines

Health r&d services; health care services; basic research (AN11): United States public contracts since 2024. Since January 2024 the line carries 605 contracts worth $994,371,189 from 8 agencies. 102 suppliers share it. $570,189,750 in 2024. $195,353,434 in 2025. $228,828,005 in 2026.

Assay record ASY-US-1XZEVCG19I · Cite as: Assay Systems, “Health r&d services; health care services; basic research (AN11): United States public contracts since 2024”, https://assay-systems.com/register/us/line/health-r-d-services/

The line

Since January 2024 the line carries 605 contracts worth $994,371,189 from 8 agencies. 102 suppliers share it.

$570,189,750 in 2024. $195,353,434 in 2025. $228,828,005 in 2026.

Suppliers in the line, by value since 2024

The extract for this line

Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.

Largest suppliers in the line

Share of the line held by each of its largest suppliers, by value, in the USAspending register.

SHIONOGI INC15.7%4J THERAPEUTICS INC6.3%BATTELLE MEMORIAL INSTITUTE4.8%PATTERN BIOSCIENCE, INC.2.3%SAPPHIROS LLC2.3%SOLVENTUM US LLC2.0%PRENOSIS, INC2.0%SYNEDGEN, INC.1.9%FLOSONICS MEDICAL LLC1.5%PARTNER THERAPEUTICS, INC.1.3%

All suppliers in United States, A to Z

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.